March 24, 2017
… From shareholding “Stockholm syndrome” – a survival strategy!
Considered irrational in light of the danger or risk endured by our portfolios
Critical information ahead of “our” universe’s open! I provide intelligence and analysis for short and near-term investment.
… Companies in my trading headlights with after and pre-market indications … six (6) – 5 BUY and 1 SELL
The sector is what it is, until it isn’t and even then it doesn’t seem to be…
Readership is a team sport, are you on it?
March 23, 2017
What are the main issues of “our” universe – trading based on the lack of investor apprises and confidence
… The iShares NASDAQ Biotechnology (IBB) closed DOWN -0.32%.
… Pre-open indications: 2 hits and 2 miss
… Q4 and FY16 reporting: Cytori (CYTX), Neuralstem (CUR) and Verastem (VSTM)
I answer one question, in which company should investors put, keep and commit their money
March 22, 2017
BLCM closed DOWN -$1.47 at $12.90 Thursday, having been UP +$0.46 to $14.37 and is DOWN -$0.16 or -1.24% in the aftermarket
March 21, 2017
RGNX drops $2.00 or -8.23% to $22.10, the pre-market is down -$1.35 or -6.11% 3.7 M shares are priced at $20.50
March 17, 2017
Priced at $0.26 … Most of the proceeds are spoken for to many past investors having negotiated a $11 M note payment schedule with Whitebox Advisors and total liabilities of $53.9 M as of Sept. 30 including a $135,000 6% senior unsecured note that matured in 2011, an 8% unsecured note for $50 K held by a related party, and a mortgage for 10.3 M at 12%. NWBO is DOWN -$0.098 or -28.43% to $0.25
The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.